Germline PTEN Promoter Mutations and Deletions in Cowden/Bannayan-Riley-Ruvalcaba Syndrome Result in Aberrant PTEN Protein and Dysregulation of the Phosphoinositol-3-Kinase/Akt Pathway

作者: Xiao-Ping Zhou , Kristin A. Waite , Robert Pilarski , Heather Hampel , Magali J. Fernandez

DOI: 10.1086/377109

关键词:

摘要: Germline intragenic mutations in PTEN are associated with 80% of patients Cowden syndrome (CS) and 60% Bannayan-Riley-Ruvalcaba (BRRS). The underlying genetic causes remain to be determined a considerable proportion classic CS BRRS without polymerase chain reaction (PCR)-detectable mutation. We hypothesized that gross gene deletions the promoter might alternatively account for subset apparently mutation-negative BRRS. Using real time multiplex PCR techniques, we identified three germline hemizygous 122 (N=95) or (N=27). Fine mapping suggested one deletion encompassed whole other two included exon 1 exons 1–5 PTEN, respectively. Two were diagnosed BRRS, patient was BRRS/CS overlap (features both). Thus 3 (11%) 27 BRRS/CS-overlap had deletions. Analysis revealed nine cases (7.4%) harboring heterozygous mutations. All CS, representing almost 10% all subjects CS. Eight breast cancers and/or benign tumors but, otherwise, oligo-organ involvement. protein analysis, from deletion-positive five PTEN-promoter-mutation–positive samples, 50% reduction multiple bands immunoreactive protein, In contrast, control samples showed only expected band. Further, an elevated level phosphorylated Akt detected promoter-mutation–positive compared controls, indicating absence marked functional PTEN. These data suggest PCR-detected offered clinical analysis promoter-mutation

参考文章(25)
Lisa Patel, Ian Pass, Phil Coxon, C.Peter Downes, Stephen A. Smith, Colin H. Macphee, Tumor suppressor and anti-inflammatory actions of PPARγ agonists are mediated via upregulation of PTEN Current Biology. ,vol. 11, pp. 764- 768 ,(2001) , 10.1016/S0960-9822(01)00225-1
Robert J. Gorlin, M. Michael Cohen, Lawrence M. Condon, Barbara A. Burke, Bannayan-Riley-Ruvalcaba syndrome. American Journal of Medical Genetics. ,vol. 44, pp. 307- 314 ,(1992) , 10.1002/AJMG.1320440309
Xiao-Ping Zhou, Oliver Gimm, Heather Hampel, Theodore Niemann, Michael J. Walker, Charis Eng, Epigenetic PTEN Silencing in Malignant Melanomas without PTEN Mutation American Journal of Pathology. ,vol. 157, pp. 1123- 1128 ,(2000) , 10.1016/S0002-9440(10)64627-5
Kristin A. Waite, Charis Eng, Protean PTEN: Form and Function American Journal of Human Genetics. ,vol. 70, pp. 829- 844 ,(2002) , 10.1086/340026
Debbie J. Marsh, Patricia L. M. Dahia, Zimu Zheng, Danny Liaw, Ramon Parsons, Robert J. Gorlin, Charis Eng, Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nature Genetics. ,vol. 16, pp. 333- 334 ,(1997) , 10.1038/NG0897-333
S. F. Ahmed, A. Cheng, L. Dovey, J. R. Hawkins, H. Martin, J. Rowland, N. Shimura, A. D. Tait, I. A. Hughes, Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome. The Journal of Clinical Endocrinology and Metabolism. ,vol. 85, pp. 658- 665 ,(2000) , 10.1210/JCEM.85.2.6337
C. Eng, Will the real Cowden syndrome please stand up: revised diagnostic criteria Journal of Medical Genetics. ,vol. 37, pp. 828- 830 ,(2000) , 10.1136/JMG.37.11.828
Xiaoyang Sheng, Dimpy Koul, Juinn-Lin Liu, Ta-Jen Liu, W.K.Alfred Yung, Promoter Analysis of Tumor Suppressor Gene PTEN: Identification of Minimum Promoter Region Biochemical and Biophysical Research Communications. ,vol. 292, pp. 422- 426 ,(2002) , 10.1006/BBRC.2002.6662
Karen D. Tsuchiya, Georgia Wiesner, Suzanne B. Cassidy, Chanin Limwongse, John T. Boyle, Stuart Schwartz, Deletion 10q23.2-q23.33 in a patient with gastrointestinal juvenile polyposis and other features of a Cowden-like syndrome Genes, Chromosomes and Cancer. ,vol. 21, pp. 113- 118 ,(1998) , 10.1002/(SICI)1098-2264(199802)21:2<113::AID-GCC6>3.0.CO;2-3